Center Laboratories, Inc. (TPEX:4123)

Taiwan · Delayed Price · Currency is TWD

41.40

-0.25 (-0.60%)

Mar 26, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Division			950.53M	767.80M	500.31M	601.10M	769.34M
Pharmaceutical Division Growth			23.80%	53.47%	-16.77%	-21.87%	8.09%
Adjustment and Write-Off			-18.72M	-1.52M	-1.64M	-75.76M	-169.09M
Shengzhi Venture			16.14M	-	-	385.00K	4.00K
Shengzhi Venture Growth			-	-	-	9525.00%	-99.99%
Fenghua Sector/Department			446.06M	-	-	189.88M	837.43M
Fenghua Sector/Department Growth			-	-	-	-77.33%	-34.10%
Other Department			-	1.44M	1.44M	1.44M	-
Other Department Growth			-	0%	0.07%	-	-
Total			1.39B	767.72M	500.11M	717.05M	1.44B
Total Growth			81.58%	53.51%	-30.25%	-50.12%	-93.36%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			1.08B	767.72M	500.11M	630.79M	860.31M
Taiwan Growth			40.97%	53.51%	-20.72%	-26.68%	-7.91%
China			297.06M	-	-	-	-
Others			14.72M	-	-	3.19M	15.29M
Others Growth			-	-	-	-79.13%	-98.90%
Mainland China			-	-	-	83.07M	562.08M
Mainland China Growth			-	-	-	-85.22%	-96.59%
Total			1.39B	767.72M	500.11M	717.05M	1.44B
Total Growth			81.58%	53.51%	-30.25%	-50.12%	-93.36%

Source: S&P Global Market Intelligence.